Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism

Molecular Endocrinology

Volumn 21, Issue 5, 2007, Pages 1095-1107

  Bassett, J H Duncan ^a   O'Shea, Patrick J ^a   Sriskantharajah, Srividya ^a   Rabier, Bénédicte ^b,c   Boyde, Alan ^d   Howell, Peter G T ^d,e   Weiss, Roy E ^f   Roux, Jean Paul ^b   Malaval, Luc ^b   Clement Lacroix, Phillipe ^g   Samarut, Jacques ^h   Chassande, Olivier ^b,c   Williams, Graham R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF CHICAGO   (United States)

^g Proskelia a Galapagos Company   (France)

^h UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE MINERALIZATION; CONTROLLED STUDY; DRUG TARGETING; ECTOPIC HORMONE PRODUCTION; ENCHONDRAL OSSIFICATION; GENE EXPRESSION; HORMONE DEFICIENCY; HYPERTHYROIDISM; JUVENILE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; SKELETON; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

MUS;

EID: 34250886538     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0033     Document Type: Article

References (50)

1. Kanis JA, Johnell O 2005 Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16:229-238
2. Ray NF, Chan JK, Thamer M, Melton III LJ 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24-35
3. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M 2006 Review: developmental origins of osteoporotic fracture. Osteoporos Int 17:337-347
4. Zamora SA, Rizzoli R, Belli DC, Slosman DO, Bonjour JP 1999 Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab 84:4541-4544
5. Riggs BL, Khosla S, Melton III LJ 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302
6. Reynolds RM, Dennison EM, Walker BR, Syddall HE, Wood PJ, Andrew R, Phillips DI, Cooper C 2005 Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcif Tissue Int 77:134-138
7. Dennison EM, Syddall HE, Rodriguez S, Voropanov A, Day IN, Cooper C 2004 Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass. J Clin Endocrinol Metab 89:4898-4903
8. Murphy E, Williams GR 2004 The thyroid and the skeleton. Clin Endocrinol (Oxf) 61:285-298
9. Huopio J, Honkanen R, Jurvelin J, Saarikoski S, Alhava E, Kroger H 2005 Role of chronic health disorders in perimenopausal fractures. Osteoporos Int 16:1404-1411
10. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P 1998 Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338:712-718
11. Vestergaard P, Rejnmark L, Mosekilde L 2005 Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 77:139-144
12. Bauer DC, Ettinger B, Nevitt MC, Stone KL 2001 Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561-568
13. Kim DJ, Khang YH, Koh JM, Shong YK, Kim GS 2006 Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clin Endocrinol (Oxf) 64:86-90
14. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC 1993 Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 43:107-109
15. Segni M, Leonardi E, Mazzoncini B, Pucarelli I, Pasquino AM 1999 Special features of Graves' disease in early childhood. Thyroid 9:871-877
16. Rivkees SA, Bode HH, Crawford JD 1988 Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J Med 318:599-602
17. Bassett JH, Williams GR 2003 The molecular actions of thyroid hormone in bone. Trends Endocrinol Metab 14:356-364
18. Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner JM, Curran T 1996 Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor β: evidence for tissue-specific modulation of receptor function. EMBO J 15:3006-3015
19. Gauthier K, Chassande O, Plateroti M, Roux JP, Legrand C, Pain B, Rousset B, Weiss R, Trouillas J, Samarut J 1999 Different functions for the thyroid hormone receptors TRα and TRβ in the control of thyroid hormone production and post-natal development. EMBO J 18:623-631
20. Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG 1976 Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 58:529-534
21. Allain TJ, Chambers TJ, Flanagan AM, McGregor AM 1992 Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. J Endocrinol 133:327-331
22. Klaushofer K, Hoffmann O, Gleispach H, Leis HJ, Czerwenka E, Koller K, Peterlik M 1989 Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J Bone Miner Res 4:305-312
23. Britto JM, Fenton AJ, Holloway WR, Nicholson GC 1994 Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 134:169-176
24. Wikstrom L, Johansson C, Salto C, Barlow C, Campos Barros A, Baas F, Forrest D, Thoren P, Vennstrom B 1998 Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α 1. EMBO J 17:455-461
25. Salto C, Kindblom JM, Johansson C, Wang Z, Gullberg H, Nordstrom K, Mansen A, Ohlsson C, Thoren P, Forrest D, Vennstrom B 2001 Ablation of TRα2 and a concomitant overexpression of α1 yields a mixed hypo- and hyperthyroid phenotype in mice. Mol Endocrinol 15:2115-2128
26. Fraichard A, Chassande O, Plateroti M, Roux JP, Trouillas J, Dehay C, Legrand C, Gauthier K, Kedinger M, Malaval L, Rousset B, Samarut J 1997 The T3R α gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J 16:4412-4420
27. Gauthier K, Plateroti M, Harvey CB, Williams GR, Weiss RE, Refetoff S, Willott JF, Sundin V, Roux JP, Malaval L, Hara M, Samarut J, Chassande O 2001 Genetic analysis reveals different functions for the products of the thyroid hormone receptor α locus. Mol Cell Biol 21:4748-4760
28. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennstrom B, Forrest D 1999 Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13:1329-1341
29. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M 2003 TSH is a negative regulator of skeletal remodeling. Cell 115:151-162
30. Macchia PE, Takeuchi Y, Kawai T, Cua K, Gauthier K, Chassande O, Seo H, Hayashi Y, Samarut J, Murata Y, Weiss RE, Refetoff S 2001 Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor α. Proc Natl Acad Sci USA 98:349-354
31. Stevens DA, Hasserjian RP, Robson H, Siebler T, Shalet SM, Williams GR 2000 Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res 15:2431-2442
32. O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR 2003 A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol 17:1410-1424
33. O'Shea PJ, Bassett JH, Sriskantharajah S, Ying H, Cheng SY, Williams GR 2005 Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor α1 or β. Mol Endocrinol 19:3045-3059
34. Stevens DA, Harvey CB, Scott AJ, O'Shea PJ, Barnard JC, Williams AJ, Brady G, Samarut J, Chassande O, Williams GR 2003 Thyroid hormone activates fibroblast growth factor receptor-1 in bone. Mol Endocrinol 17:1751-1766
35. Barnard JC, Williams AJ, Rabier B, Chassande O, Samarut J, Cheng SY, Bassett JH, Williams GR 2005 Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology 146:5568-5580
36. Eriksen EF, Mosekilde L, Melsen F 1986 Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle. Bone 7:101-108
37. Mosekilde L, Melsen F 1978 Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II. Bone histomorphometry. Acta Endocrinol (Copenh) 87:751-758
38. Butler AA, Le Roith D 2001 Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63:141-164
39. 3H]thymidine incorporation and IGF-I receptor mRNA in cultured rat epiphyseal chondrocytes. J Endocrinol 135:115-123
40. Isaksson OG, Lindahl A, Nilsson A, Isgaard J 1987 Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8:426-438
41. O'Shea PJ, Bassett JHD, Cheng SY, Williams GR 2006 Characterization of skeletal phenotypes of TRα1PV and TRβPV mutant mice: implications for tissue thyroid status and T3 target gene expression. Nuclear Receptor Signaling 4:e011 http://www.nursa.org/article.cfm?doi=10.1621/nrs.04011
42. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ 2006 Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789-799
43. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF 2002 Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA 99:15776-15781
44. Boersma B, Otten BJ, Stoelinga GB, Wit JM 1996 Catch-up growth after prolonged hypothyroidism. Eur J Pediatr 155:362-367
45. Friedrichsen S, Christ S, Heuer H, Schafer MK, Mansouri A, Bauer K, Visser TJ 2003 Regulation of iodothyronine deiodinases in the Pax8-/- mouse model of congenital hypothyroidism. Endocrinology 144:777-784
46. Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J, Refetoff S 1999 Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid 9:1265-1271
47. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P 2002 High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233
48. Lloyd G 1987 Atomic number and crystallographic contrast images with the SEM: a review of backscattered electron techniques. Mineralogical Magazine 51:3-19
49. Boyde A, Travers R, Glorieux FH, Jones SJ 1999 The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int 64:185-190
50. Boyde A, Firth EC 2005 Musculoskeletal responses of 2-year-old thoroughbred horses to early training. 8. Quantitative back-scattered electron scanning electron microscopy and confocal fluorescence microscopy of the epiphysis of the third metacarpal bone. NZ Vet J 53:123-132